{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:05:39Z","timestamp":1773659139745,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008289","name":"James Madison University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jns.2013.08.022","type":"journal-article","created":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T16:02:33Z","timestamp":1377360153000},"page":"48-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type"],"prefix":"10.1016","volume":"335","author":[{"given":"Syuichi","family":"Tetsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Kasashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michito","family":"Namekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Natsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Takiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imaharu","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2013.08.022_bb0005","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2013.08.022_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1531-8249(199906)45:6<805::AID-ANA18>3.0.CO;2-G","article-title":"Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal","volume":"45","author":"Greenlee","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.410190117","article-title":"Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration","volume":"19","author":"Greenlee","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-5728(96)00205-6","article-title":"Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease","volume":"74","author":"Graus","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2013.08.022_bb0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0896-6273(93)90077-5","article-title":"Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system","volume":"11","author":"Buckanovich","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2013.08.022_bb0040","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2013.08.022_bb0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplastic accompaniments","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0060","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2013.08.022_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/379466a0","article-title":"Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry","volume":"379","author":"Wilm","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jns.2013.08.022_bb0070","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1128\/JVI.02179-08","article-title":"Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein","volume":"83","author":"Hara","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jns.2013.08.022_bb0075","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1046\/j.1460-9568.2002.02001.x","article-title":"Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility","volume":"15","author":"Jost","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jns.2013.08.022_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1789.1997.tb00019.x","article-title":"A novel autoantibody in paraneoplastic sensory-dominant neuropathy","volume":"17","author":"Arawaka","year":"1997","journal-title":"Neuropathology"},{"key":"10.1016\/j.jns.2013.08.022_bb0085","first-page":"597","article-title":"A novel autoantibody in paraneoplastic sensory-dominant neuropathy reacts with brain-type creatine kinase","volume":"1","author":"Arawaka","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jns.2013.08.022_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-510X(91)90198-G","article-title":"Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model","volume":"106","author":"Graus","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2013.08.022_bb0100","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.45.10.1873","article-title":"Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice","volume":"45","author":"Sillevis Smitt","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.08.022_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-065X.2012.01144.x","article-title":"Neural antigen-specific autoimmune disorders","volume":"248","author":"Iorio","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jns.2013.08.022_bb0110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/NEN.0b013e3181f0c82b","article-title":"Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures","volume":"69","author":"Greenlee","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2013.08.022_bb0115","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1146\/annurev.bi.54.070185.004151","article-title":"The creatine-creatine phosphate energy shuttle","volume":"54","author":"Bessman","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jns.2013.08.022_bb0120","first-page":"5399","article-title":"Elevated serum creatine kinase BB levels in patients with small cell lung cancer","volume":"44","author":"Carney","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.jns.2013.08.022_bb0125","first-page":"129","article-title":"Evaluation of carcinoembryonic antigen (CEA) and brain-type creatine kinase (CK-BB) in serum from patients with carcinoma of the lung","volume":"38","author":"Nikli\u0144ski","year":"1991","journal-title":"Neoplasma"},{"key":"10.1016\/j.jns.2013.08.022_bb0130","first-page":"645","article-title":"Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung","volume":"38","author":"Nikli\u0144ski","year":"1991","journal-title":"Neoplasma"},{"key":"10.1016\/j.jns.2013.08.022_bb0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0009-9120(95)00010-7","article-title":"Quantification of creatine kinase BB isoenzyme in tumor cytosols and serum with an ultrasensitive time-resolved immunofluorometric technique","volume":"28","author":"Zarghami","year":"1995","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jns.2013.08.022_bb0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/bjc.1996.66","article-title":"Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients","volume":"73","author":"Zarghami","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jns.2013.08.022_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2004.08.047","article-title":"Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker","volume":"96","author":"Huddleston","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jns.2013.08.022_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cccn.2005.05.028","article-title":"Increased creatine kinase BB activity and CKB mRNA expression in patients with hematologic disorders: relation to methylation status of the CKB promoter","volume":"361","author":"Ishikawa","year":"2005","journal-title":"Clin Chim Acta"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13028712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13028712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:42:25Z","timestamp":1758382945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13028712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0022510X13028712"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.08.022","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2013.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}